Morgan Stanley
- SEC CIK
- 0000895421
- Latest filing
- Aug 13, 2026
ENTX holding history
Entera Bio Ltd. in every 13F filed by Morgan Stanley, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ENTX overviewAll 13F holders of ENTXFull Q2 2026 holdings
- Shares (Q2 2026)
- 500
- Value
- $885
- % of portfolio
- <0.1%
- Quarters held
- 13
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 500 | $885 | <0.1% | +100+25.0% | Added | Holders |
| Q1 2026 | 400 | $444 | <0.1% | +400 | New | Holders |
| Q1 2024 | 0 | $0 | 0.0% | −1,000−100.0% | Sold out | Holders |
| Q4 2023 | 1,000 | $600 | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 1,000 | $725 | <0.1% | −100−9.1% | Reduced | Holders |
| Q2 2023 | 1,100 | $928 | <0.1% | +100+10.0% | Added | Holders |
| Q1 2023 | 1,000 | $1.16K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 1,000 | $730 | <0.1% | −35,166−97.2% | Reduced | Holders |
| Q3 2022 | 36,166 | $38.0K | <0.1% | +33,400+1,207.5% | Added | Holders |
| Q2 2022 | 2,766 | $4.00K | <0.1% | −2,190−44.2% | Reduced | Holders |
| Q1 2022 | 4,956 | $14.0K | <0.1% | −1,012−17.0% | Reduced | Holders |
| Q4 2021 | 5,968 | $17.0K | <0.1% | +590+11.0% | Added | Holders |
| Q3 2021 | 5,378 | $25.0K | <0.1% | +3,188+145.6% | Added | Holders |
| Q2 2021 | 2,190 | $13.0K | <0.1% | +2,190 | New | Holders |